We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Hoping to discourage other states from following Pennsylvania’s lead, generic heavyweight Mylan Laboratories has dropped out of the state’s drug discount program for seniors, arguing the newly required 14 percent rebate on generic drugs is too high.